LBO — EDEN MEDICAL CENTER
IRR: 30.0% | MOIC: 3.71x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
30.0%
IRR
3.71x
MOIC
$107.8M
Entry EV
$258.2M
Exit EV
$55.5M
Equity Invested
Sources & Uses
S&UTotal · $107.8M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $41.9M | 38.8% | |
| Sub Debt | $10.5M | 9.7% | |
| Equity | $55.5M | 51.5% | |
| Enterprise Value | $104.6M | 97.1% | |
| Transaction Fees | $3.1M | 2.9% | |
| Total Uses | $107.8M | 100.0% |
Interpretation
INTAt 3.71x MOIC and 30.0% IRR over 5 years, this deal exceeds the typical 20% hurdle — strong candidate.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $24.6M |
| Exit Ev | $258.2M |
| Net Debt At Exit | $52.2M |
| Equity At Exit | $206.0M |
| Equity Invested | $55.5M |
| Total Value Created | $150.5M |
| Value From Growth | $148.3M |
| Value From Multiple | $5.2M |
| Value From Deleveraging | $0.1M |